Company Overview and News

 
Navy Sticks With Current LCS Synthetic Aperture Sonar Minehunters After Review

2018-05-25 defensedaily
The U.S. Navy is sticking with the Littoral Combat Ship (LCS) Mine Countermeasures (MCM) Synthetic Aperture Sonar (SAS) program of record after finding no alternates provide adequate performance, according to a report to Congress.

 
Northrop Grumman to Participate in Bernstein’s 34th Annual Strategic Decisions Conference

2018-05-23 globenewswire
FALLS CHURCH, Va., May 23, 2018 (GLOBE NEWSWIRE) -- Northrop Grumman Corporation (NYSE:NOC) will participate in Bernstein’s 34th Annual Strategic Decisions Conference on Thursday, May 31. Kathy Warden, president and chief operating officer, and Ken Bedingfield, corporate vice president and chief financial officer, will present beginning at 9:00 a.m. Eastern time. The presentation will be webcast live at www.

 
General Dynamics: Adequate Growth Potential

2018-05-23 seekingalpha
Share price has lagged behind industry peers over the past year, while operating results show mixed fortunes as well.

 
F-16 fighter jet production can make India an export hub: Lockheed Martin

2018-05-23 livemint
Washington: Global aerospace giant Lockheed Martin on Tuesday said its proposal to manufacture custom-built F-16 fighter jets in India will make the country an export hub and give it access to an estimated $165 billion fighter aircraft market over the next few decades.

 
NGC, US Army Install Improved Early Missile Warning in Japan

2018-05-23 asdnews
The U.S. Army and Northrop Grumman Corporation (NYSE: NOC) have deployed enhanced Joint Tactical Ground Station (JTAGS) capabilities in Japan to advance battlespace awareness and missile defense.

 
3 Dividend Growth Stocks Delivering Higher Returns To Shareholders

2018-05-22 seekingalpha
I monitor the list of dividend increases every week as part of my review process of existing and potential portfolio holdings.

 
US warfighters begin receiving upgraded JTAGS system

2018-05-22 janes
The US Army and Northrop Grumman have deployed the first improved Joint Tactical Ground Station (JTAGS) that modifies its in-theatre missile warning capability.

 
Boeing Secures Navy Deal to Modernize F/A-18 & EA-18G Jets

2018-05-22 zacks
The Boeing Company (BA - Free Report) recently won a task order to support F/A-18 A-F and EA-18G aircrafts for the U.S. Navy and the government of Australia. Work related to the deal is scheduled to be over by July 2022.

 
4 Notable Dividend Increases From the Past Week — Including Lam Research Corproation

2018-05-21 investorplace
The S&P 500 Index ended a fairly quiet week nearly unchanged last week. With a fundamentally strong earnings season wrapping up, several businesses delivered additional good news in the form of payout raises.

 
SpeedNews Defense & Space

2018-05-18 aviationweek
GENERAL ATOMICS AERONAUTICAL SYSTEMS INC. has $206m U.S. Air Force contract to retrofit 122 MQ-9 Block 5 aircraft. AURORA FLIGHT SCIENCES CORP. and the Office of Naval Research received Howard Hughes innovation award from the American Helicopter Society for their joint work on Autonomous Aerial Cargo Utility System (AACUS). AVIC of China completed airborne weapon firing tests of Z-19E armed helicopter.

 
SpeedNews Defense & Space

2018-05-18 aviationweek
GENERAL ATOMICS AERONAUTICAL SYSTEMS INC. has $206m U.S. Air Force contract to retrofit 122 MQ-9 Block 5 aircraft. AURORA FLIGHT SCIENCES CORP. and the Office of Naval Research received Howard Hughes innovation award from the American Helicopter Society for their joint work on Autonomous Aerial Cargo Utility System (AACUS). AVIC of China completed airborne weapon firing tests of Z-19E armed helicopter.

 
Why Northrop Grumman Corporation Is a Top-5 Holding | InvestorPlace

2018-05-17 investorplace
Northrop Grumman Corporation (NYSE:NOC) got its start as an aerospace and defense firm in WWII building bombers for the Norwegians.

 
Macy's And Micron Ignite A Rally - Cramer's Mad Money (5/16/18)

2018-05-17 seekingalpha
Stocks discussed on the in-depth session of Jim Cramer's Mad Money TV Program, Wednesday, May 16.

Related Articles

HRTX : Heron Therapeutics Analysis and Research Report

2018-05-25 - Asif

Overview Heron is a commercial-stage biotechnology company focused on improving the lives of patients by developing best-in-class treatments that address some of the most important unmet patient needs. Heron Therapeutics is developing novel, patient-focused solutions that apply its innovative science and technologies to already approved pharmacological agents for patients suffering from cancer or pain. On August 9, 2016, its first commercial product, SUSTOL, was approved by the FDA. The company developed SUSTOL for the prevention of chemotherapy-induced nausea and vomiting (“CINV”). SUSTOL is indicated, in combination with other antiemetics, in adults for the prevention of acute and delayed nausea and vomiting associated with initial and repeat courses of moderately emetogenic chemotherapy (“MEC”) or anthracycline and cyclophosphamide (“AC”) combination chemotherapy regimens. The company commenced commercial sales of SUSTOL in the U.S. in October 2016. On November 9, 2017...

ACIA: Acacia Communications Analysis and Research Report

2018-05-25 - Asif

Overview The company's mission is to deliver high-speed coherent optical interconnect products that transform communications networks, relied upon by cloud infrastructure operators and content and communication service providers, through improvements in performance and capacity and reductions in associated costs. By converting optical interconnect technology to a silicon-based technology, a process the company refer to as the siliconization of optical interconnect, the company believe Acacia Communications is leading a disruption that is analogous to the computing industry’s integration of multiple functions into a microprocessor. The company's products include a family of low-power coherent digital signal processor application-specific integrated circuits, or DSP ASICs, and silicon photonic integrated circuits, or silicon PICs, which Acacia Communications has integrated into families of optical interconnect modules with transmission speeds ranging from 100 to 400 gigabits per ...

ANTH: Anthera Pharmaceuticals Analysis and Research Report

2018-05-21 - Asif

Overview Anthera Pharmaceuticals, Inc. is a biopharmaceutical company focused on advancing the development and commercialization of innovative medicines that benefit patients with unmet medical needs. The company currently have two compounds in development, Sollpura and blisibimod. The company licensed Sollpura from Eli Lilly & Co (“Eli Lilly”) in July 2014. Sollpura is a novel non-porcine investigational Pancreatic Enzyme Replacement Therapy (“PERT”) intended for the treatment of patients with Exocrine Pancreatic Insufficiency (“EPI”), often seen in patients with cystic fibrosis and other conditions. The company licensed blisibimod from Amgen, Inc. (“Amgen”) in December 2007. Blisibimod targets B-cell activating factor, or BAFF, which has been shown to be elevated in a variety of B-cell mediated autoimmune diseases, including Immunoglobulin A nephropathy, or IgA nephropathy. Sollpura The exocrine pancreas is responsible for synthesis and secretion of digestive en...

CUSIP: 666807102